TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 121 filers reported holding TRANSMEDICS GROUP INC in Q2 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,618,677 | -26.5% | 358,332 | +12.7% | 0.00% | -20.0% |
Q2 2023 | $26,691,700 | +258.8% | 317,834 | +223.6% | 0.01% | +150.0% |
Q1 2023 | $7,438,125 | -1.4% | 98,219 | -19.6% | 0.00% | 0.0% |
Q4 2022 | $7,540,702 | +4.5% | 122,176 | -29.3% | 0.00% | 0.0% |
Q3 2022 | $7,218,000 | +496.5% | 172,908 | +349.5% | 0.00% | – |
Q2 2022 | $1,210,000 | +71.6% | 38,466 | +46.9% | 0.00% | – |
Q1 2022 | $705,000 | +138.2% | 26,179 | +69.6% | 0.00% | – |
Q4 2021 | $296,000 | -56.9% | 15,439 | -25.5% | 0.00% | – |
Q3 2021 | $686,000 | -18.5% | 20,717 | -18.3% | 0.00% | – |
Q2 2021 | $842,000 | -41.8% | 25,367 | -27.3% | 0.00% | – |
Q1 2021 | $1,447,000 | +502.9% | 34,869 | +188.7% | 0.00% | – |
Q4 2020 | $240,000 | +36.4% | 12,077 | -5.6% | 0.00% | – |
Q3 2020 | $176,000 | -41.7% | 12,799 | -24.2% | 0.00% | – |
Q2 2020 | $302,000 | +69.7% | 16,879 | +14.6% | 0.00% | – |
Q1 2020 | $178,000 | – | 14,724 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Divisadero Street Capital Management, LP | 325,000 | $27,293,500 | 7.89% |
Ophir Asset Management Pty Ltd | 418,366 | $35,134,377 | 7.32% |
Sandhill Capital Partners LLC | 812,844 | $68,262,667 | 6.22% |
Kent Lake Capital LLC | 119,129 | $10,004,453 | 4.60% |
Eagle Health Investments LP | 232,032 | $19,486,047 | 3.64% |
NEXT CENTURY GROWTH INVESTORS LLC | 442,942 | $37,198,269 | 3.58% |
Bullseye Asset Management LLC | 83,012 | $6,971 | 3.50% |
First Light Asset Management, LLC | 377,464 | $31,699,427 | 2.48% |
Nicholas Investment Partners, LP | 367,631 | $30,873,651 | 2.11% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 671,716 | $56,410,710 | 2.09% |